Life sciences therapies are moving away from a one-size-fits-all approach to a targeted approach using a patient's own genetic information and immune system to treat previously incurable diseases.
Shankar Suryanarayanan
Advertisement
Articles by Shankar Suryanarayanan
Advertisement
Latest Updated Articles
Operations: Gateway to Success in Cell and Gene TherapiesPublished: April 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
5
